Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biotricity, Inc. stock logo
BTCY
Biotricity
$0.53
+10.4%
$0.44
$0.19
$0.83
$13.20M1.1238,264 shs9,323 shs
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
$1.17
-6.4%
$1.18
$0.40
$1.65
$14.77M2.3703,803 shs14.71 million shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$1.02
+39.7%
$1.00
$0.59
$4.49
$17.77M3.6977,540 shs49.91 million shs
Pheton Holdings Ltd stock logo
PTHL
Pheton
$0.60
+0.2%
$13.11
$0.51
$32.00
$3.95MN/A3.27 million shs433,541 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biotricity, Inc. stock logo
BTCY
Biotricity
+10.42%-15.93%+6.21%+3.92%+26.79%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-6.40%-7.87%-13.97%+146.32%+9.35%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
+39.73%+30.07%-17.07%-17.07%+3.56%
Pheton Holdings Ltd stock logo
PTHL
Pheton
+0.20%-5.17%-97.45%-90.90%+59,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
3.3886 of 5 stars
3.55.00.00.04.11.70.0
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
2.4462 of 5 stars
3.55.00.00.00.61.70.0
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biotricity, Inc. stock logo
BTCY
Biotricity
2.00
HoldN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
3.00
Buy$2.0070.94% Upside
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.00
Buy$5.00390.20% Upside
Pheton Holdings Ltd stock logo
PTHL
Pheton
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PTHL, IINN, BTCY, and NXL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/2/2025
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/2/2025
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
Litchfield Hills Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$2.00
(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biotricity, Inc. stock logo
BTCY
Biotricity
$12.06M1.09N/AN/A($1.30) per share-0.41
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/A$0.34 per shareN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$174.81K101.63N/AN/A$0.34 per share3.00
Pheton Holdings Ltd stock logo
PTHL
Pheton
$450K8.77N/AN/A$0.94 per share0.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biotricity, Inc. stock logo
BTCY
Biotricity
-$14.09M-$0.21N/AN/A-80.42%N/A-188.47%N/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
-$11.05MN/A0.00N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$7.61M-$0.76N/AN/A-5,057.14%-209.20%-186.87%N/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
-$660KN/A0.00N/AN/AN/AN/AN/A

Latest PTHL, IINN, BTCY, and NXL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.14-$0.10+$0.04-$0.10$0.04 million$0.07 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biotricity, Inc. stock logo
BTCY
Biotricity
N/AN/AN/AN/AN/A
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biotricity, Inc. stock logo
BTCY
Biotricity
N/A
0.23
0.10
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
0.09
2.02
1.89
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
10.43
10.14
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
12.39
12.17

Institutional Ownership

CompanyInstitutional Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
3.89%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
12.72%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A

Insider Ownership

CompanyInsider Ownership
Biotricity, Inc. stock logo
BTCY
Biotricity
10.10%
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
29.40%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
25.26%
Pheton Holdings Ltd stock logo
PTHL
Pheton
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Biotricity, Inc. stock logo
BTCY
Biotricity
4024.91 million22.08 millionOptionable
Inspira Technologies OXY B.H.N. Ltd. stock logo
IINN
Inspira Technologies OXY B.H.N.
2012.62 million8.91 millionNot Optionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
317.42 million13.02 millionNot Optionable
Pheton Holdings Ltd stock logo
PTHL
Pheton
116.58 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Biotricity stock logo

Biotricity NASDAQ:BTCY

$0.53 +0.05 (+10.42%)
As of 08/22/2025 03:51 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Inspira Technologies OXY B.H.N. stock logo

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.17 -0.08 (-6.40%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$1.16 0.00 (-0.43%)
As of 08/22/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$1.02 +0.29 (+39.73%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$0.96 -0.06 (-6.27%)
As of 08/22/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Pheton stock logo

Pheton NASDAQ:PTHL

$0.60 +0.00 (+0.20%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$0.59 -0.01 (-1.67%)
As of 08/22/2025 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.